US Broker Ratings

RadNet, Inc. (RDNT) Stock Analysis: A 24.67% Potential Upside in the Dynamic World of Diagnostics

RadNet, Inc. (NASDAQ: RDNT) stands out in the healthcare sector as a formidable player in diagnostics and research. With a market capitalization of $4.41 billion, RadNet is making significant strides..

BridgeBio Pharma, Inc. (BBIO) Investor Outlook: Analyzing the 32.83% Potential Upside Amidst a Robust Clinical Pipeline

BridgeBio Pharma, Inc. (BBIO), a commercial-stage biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to treating genetic diseases and cancers. Based in Palo Alto, California,..

Integer Holdings Corporation (ITGR) Stock Analysis: A 29.83% Upside Potential in the Medical Devices Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors with its robust growth potential and strong analyst..

Tempus AI, Inc. (TEM) Stock Analysis: Harnessing a Robust 75.4% Revenue Growth in Health Information Services

Tempus AI, Inc. (TEM), a healthcare technology leader, is making waves in the Health Information Services industry with its impressive revenue growth and strategic collaborations. Headquartered in Chicago, the company..

Bausch + Lomb Corporation (BLCO) Stock Report: Navigating a 1.01% Potential Upside Amidst Healthcare Growth

Bausch + Lomb Corporation (NYSE: BLCO), a globally renowned name in the eye health sector, presents a complex picture for investors seeking opportunities in the healthcare industry. With a market..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 54.94% Potential Upside

Molina Healthcare Inc (NYSE: MOH), a key player in the healthcare sector, occupies a unique position in the market by focusing on providing managed healthcare services to low-income families and..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Navigating a Promising 42% Upside in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (MDGL), a biotechnology firm based in West Conshohocken, Pennsylvania, is gaining attention in the healthcare sector for its pioneering approach to treating metabolic dysfunction-associated steatohepatitis (MASH). With..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 30.71% Upside Potential

For investors with a keen eye on the healthcare sector, Bruker Corporation (NASDAQ: BRKR) presents an intriguing opportunity. As a prominent player in the medical devices industry, Bruker has established..

United Therapeutics Corporation (UTHR): Investor Outlook Reveals a 25% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR), a leading player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors seeking exposure to..

Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling a 75.95% Potential Upside in the Biotechnology Sector

Legend Biotech Corporation (NASDAQ: LEGN) stands as a formidable player in the healthcare sector, specifically within the burgeoning biotechnology industry. With a market capitalization of $7.98 billion, Legend Biotech is..

Charles River Laboratories (CRL) Stock Analysis: Navigating a Transitional Phase with Insightful Market Indicators

Charles River Laboratories International, Inc. (NYSE: CRL) stands at the intersection of innovation and essential support services within the healthcare sector, specifically in diagnostics and research. With a market capitalization..

Bristol-Myers Squibb (BMY): Analyst Ratings Signal 15.73% Upside Potential for Investors

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the healthcare sector, operates at the forefront of the drug manufacturing industry. The company, headquartered in Princeton, New Jersey, has a storied..

Alnylam Pharmaceuticals (ALNY): Analyst Consensus Highlights Strong Buy Ratings Amid Robust Pipeline

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands out in the biotechnology sector with its innovative approach to therapeutics, focusing on ribonucleic acid interference (RNAi) technology. With a market capitalization of $42.87..

CVS Health Corporation (CVS): Rating Update Reveals 30% Potential Upside, Making It a Buy for Investors

CVS Health Corporation (NYSE: CVS), a leading player in the healthcare plans industry, offers a compelling investment opportunity with notable growth potential. With a market capitalization of $76.79 billion, CVS..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating a 61.65% Potential Upside

Inspire Medical Systems, Inc. (NYSE: INSP), a specialized player in the healthcare sector, offers investors a unique opportunity in the burgeoning field of medical devices aimed at treating obstructive sleep..

Rhythm Pharmaceuticals, Inc. (RYTM): Investor Outlook with 20.96% Potential Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing the attention of investors with its significant growth prospects within the healthcare sector, particularly in the biotechnology industry. With a market capitalization of..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Potential 47% Upside Amid Biotech Innovations

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to drug development and a potential upside of 47.19%, according..

Chemed Corp (CHE) Stock Analysis: Exploring a 29.59% Potential Upside in the Healthcare Sector

Chemed Corp (CHE), a prominent player in the healthcare sector, is capturing investor attention with a potential upside of 29.59%, according to current analyst ratings. Incorporated in 1970 and headquartered..

Verona Pharma plc (VRNA) Stock Analysis: Navigating the Biotech Terrain with a $8.95 Billion Market Cap

Investors eyeing Verona Pharma plc (NASDAQ: VRNA) are stepping into the dynamic world of biotechnology, where the company is making strides in developing treatments for respiratory diseases. With a market..

Prestige Consumer Healthcare (PBH) Stock Analysis: A 15% Upside Potential Amid Steady Growth

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a noteworthy player in the Healthcare sector, specifically within the Drug Manufacturers – Specialty & Generic industry. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds